Market Cap: $1.5B
BS
Bicara Therapeutics Inc. Common Stock
BCAX
NASDAQ (NASDAQ Global Market)USD
Market Cap: $1.5B
Analysts estimated BCAX earnings of $-0.77 per share this quarter (Q1). BCAX's actual earnings were $-0.93 per share.
BCAX EPS surprise of -20.78%Analysts estimated BCAX earnings of $-0.56 per share this quarter (Q3). BCAX's actual earnings were $-0.67 per share.
BCAX EPS surprise of -19.60%Analysts estimated BCAX earnings of $-0.58 per share this quarter (Q2). BCAX's actual earnings were $-0.50 per share.
BCAX EPS surprise of 13.78%Analysts estimated BCAX earnings of $-0.42 per share this quarter (Q1). BCAX's actual earnings were $-0.68 per share.
BCAX EPS surprise of -60.68%Analysts estimated BCAX earnings of $-0.33 per share this quarter (Q4). BCAX's actual earnings were $-0.39 per share.
BCAX EPS surprise of -18.22%Analysts estimated BCAX earnings of $-0.47 per share this quarter (Q3). BCAX's actual earnings were $-1.60 per share.
BCAX EPS surprise of -241.01%